Tech Company Financing Transactions
Alume Biosciences Funding Round
Alume Biosciences closed a $13 million Series B financing round on 1/18/2023. Backers included private investors.
Transaction Overview
Company Name
Announced On
1/18/2023
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to enable further market growth and product development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery into the light.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Quyen Nguyen
Chief Financial Officer
Jim Schmidt
Chief Medical Officer
Brett Berman
VP - Operations
Dan Harvey
Browse more venture capital transactions:
Prev: 1/18/2023: Virtualtech Frontier venture capital transaction
Next: 1/18/2023: Summit Nanotech venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs